Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) has been a public health risk in several countries, and recent reports indicate the emergence of CRE in food animals. This study was conducted to investigate the occurrence, resistance patterns, and phylogenetic diversity of carbapenem-resistant E. coli (CREC) from chicken. Routine bacteriology, PCR detection of E. coli species, multiplex PCR to detect carbapenemase-encoding genes, and phylogeny of CRE E. coli were conducted. The results show that 24.36% (19/78) were identified as CREC based on the phenotypic identifications of which 17 were positive for the tested carbapenemases genes. The majority, 57.99% (11/19), of the isolates harbored multiple carbapenemase genes. Four isolates harbored all blaNDM, blaOXA, and blaIMP, and five and two different isolates harbored blaNDM and blaOXA and blaOXA and blaIMP, respectively. The meropenem, imipenem, and ertapenem MIC values for the isolates ranged from 2 μg/mL to ≥256 μg/mL. Phylogenetic grouping showed that the CREC isolates belonged to five different groups: groups A, B1, C, D, and unknown. The detection of CREC in this study shows that it has become an emerging problem in farm animals, particularly, in poultry farms. This also implies the potential public health risks posed by CRE from chicken to the consumers.

Highlights

  • Carbapenem resistance in Enterobacteriaceae is a serious emerging antimicrobial resistance (AMR) issue that has been escalating and posing challenges in treating infections caused by the resistant pathogen

  • Based on the routine microbiology, 56.7% (85/150) of the cloacal swab samples were positive for E. coli

  • The current study reports relatively higher prevalence of Carbapenem-resistant Enterobacteriaceae (CRE), 24.36% (19/78) of the total E. coli isolated from 150 cloacal swab samples collected from broiler chicken from commercial farms based on phenotypic identifications of which 17 were positive for the tested carbapenemase genes, whereas the two isolates were negative for carbapenemase genes while showing carbapenem-resistant E. coli (CREC)-positive results on Minimum Inhibitory Concentration (MIC) test by using E-test strips

Read more

Summary

Introduction

Carbapenem resistance in Enterobacteriaceae is a serious emerging antimicrobial resistance (AMR) issue that has been escalating and posing challenges in treating infections caused by the resistant pathogen. Enterobacteriaceae are inhabitants of the intestinal flora and are among the most common human pathogens that cause cystitis and pyelonephritis with fever, septicemia, pneumonia, peritonitis, meningitis, and device-associated infections [1]. Enterobacteriaceae are among the common nosocomial pathogens often causing infections through medical devices that include ventilators, intravenous catheters, urinary catheters, or wounds caused by injury or surgery [2]. Such nosocomial infections commonly affect immunocompromised patients and in patients being treated using invasive devices

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call